Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Reproductive Toxicology (Elmsford, N.Y.)|January 1, 1989
Urinary creatine as a possible marker for testicular damage: studies with the testicular toxic compound 2-methoxyethanolL Rawcliffe, D Creasy, J A TimbrellBritish Journal of Cancer|September 2, 2016
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancerJörg Kleeff, Eithne Costello, Richard Jackson, et al.JAMA|July 12, 2012
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trialJohn P Neoptolemos, Malcolm J Moore, Trevor F Cox, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 studyJuan W Valle, Daniel Palmer, Richard Jackson, et al.JAMA|September 9, 2010
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trialJohn P Neoptolemos, Deborah D Stocken, Claudio Bassi, et al.Annals of Surgery|October 26, 2017
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal AdenocarcinomaPaula Ghaneh, Jorg Kleeff, Christopher M Halloran, et al.Journal of the National Cancer Institute|December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trialWilliam Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.Pageof 1